To further investigate the clinical relationship between FOSL2 and TGF-β1 signalling, the expression of FOSL2 and p-Smad3 in 57 NSCLC samples were examined by immunohistochemical methods, and correlations of the proteins were evaluated. Here, SMAD3 is linked to non-small cell lung carcinoma.